Australia TGA ARTG recordExudate-absorbent dressing, hydrophilic-gel
Australia TGA ARTG Registered Device · Johnson & Johnson Pacific Pty Ltd · Coloplast AS · Class IIa · Started August 07, 2023
Good Name: Johnson & Johnson Pacific Pty Ltd - Exudate-absorbent dressing, hydrophilic-gel
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 07, 2023
- Effective Date
- August 07, 2023
- Name
- Coloplast AS
- Country
- Denmark
- Address
- Holtedam 1, Humlebaek, 3050
The product is intended for moist wound healing.
Access comprehensive regulatory information for Exudate-absorbent dressing, hydrophilic-gel in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Johnson & Johnson Pacific Pty Ltd, manufactured by Coloplast AS in Denmark. The device registration started on August 07, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.